{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "\n",
    "<style>\n",
    "@page { size: A4 portrait; margin: 12mm; }\n",
    "@media print {\n",
    "  .jp-Cell, .cell, .jp-OutputArea, .output, figure, img, canvas, svg, table, pre {\n",
    "    break-inside: avoid !important; page-break-inside: avoid !important;\n",
    "  }\n",
    "  h1, h2, h3 { page-break-after: avoid; }\n",
    "  * { -webkit-print-color-adjust: exact !important; print-color-adjust: exact !important; }\n",
    "}\n",
    "</style>\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Clinical Dataset Exploration Explanation Notebook\n",
    "\n",
    "narrative of `clinica/clinica_data_exploration.ipynb`."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Objectives and Dataset\n",
    "\n",
    "- Goal: characterize PD vs MSA (MSA-P, MSA-C) clinically; surface discriminative variables; prepare for integration with imaging models.\n",
    "- Classes considered: MSA-P, MSA-C,PD (MSA-P and MSA-C are sometimes merged as MSA).\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e1c52dca",
   "metadata": {},
   "source": [
    "## 1.1 Legend\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d2112417",
   "metadata": {},
   "source": [
    "| Column                                                         | Type        | Short explanation                                                                |\n",
    "| :------------------------------------------------------------- | :---------- | :------------------------------------------------------------------------------- |\n",
    "| anni_dalla_diagnosi                                            | numeric     | Years elapsed since formal diagnosis.                                            |\n",
    "| anni_dopaminoaagonisti                                         | numeric     | Duration of dopamine-agonist therapy (years).                                    |\n",
    "| anni_l_dopa                                                    | numeric     | Duration of levodopa therapy (years).                                            |\n",
    "| anno_diagnosi                                                  | numeric     | Calendar year of diagnosis.                                                      |\n",
    "| anno_esordio_disautonomia                                      | numeric     | Year of first autonomic symptom.                                                 |\n",
    "| anno_esordio_sintomi_motori                                    | numeric     | Year of first motor symptom.                                                     |\n",
    "| anno_esordio_sintomi_non_motori                                | numeric     | Year of first non-motor symptom.                                                 |\n",
    "| anno_nascita                                                   | numeric     | Year of birth.                                                                   |\n",
    "| compass_gi                                                     | numeric     | COMPASS-31 gastrointestinal sub-score.                                           |\n",
    "| compass_oh                                                     | numeric     | COMPASS-31 orthostatic hypotension sub-score.                                    |\n",
    "| compass_pupil                                                  | numeric     | COMPASS-31 pupillomotor sub-score.                                               |\n",
    "| compass_sudor                                                  | numeric     | COMPASS-31 sudomotor (sweating) sub-score.                                       |\n",
    "| compass_totale                                                 | numeric     | Total COMPASS-31 autonomic dysfunction score.                                    |\n",
    "| compass_uin                                                    | numeric     | COMPASS-31 urinary sub-score.                                                    |\n",
    "| compass_vasc                                                   | numeric     | COMPASS-31 vasomotor sub-score.                                                  |\n",
    "| delta_off_on                                                   | numeric     | Difference between UPDRS_OFF and UPDRS_ON (treatment effect).                    |\n",
    "| durata_malattia                                                | numeric     | Disease duration from onset (years).                                             |\n",
    "| eta_attuale                                                    | numeric     | Current patient age.                                                             |\n",
    "| eta_diagnosi                                                   | numeric     | Age at diagnosis.                                                                |\n",
    "| eta_esordio                                                    | numeric     | Age at first motor symptom.                                                      |\n",
    "| h_and_y                                                        | numeric     | Hoehn & Yahr stage (1‚Äì5).                                                        |\n",
    "| ledd                                                           | numeric     | Levodopa equivalent daily dose (mg/day).                                         |\n",
    "| ledd_per_anno                                                  | numeric     | LEDD normalized per year of disease.                                             |\n",
    "| n_anomalie_mri                                                 | numeric     | Number of abnormal MRI findings.                                                 |\n",
    "| n_red_flags_msa                                                | numeric     | Count of MSA ‚Äúred-flag‚Äù features (per MDS).                                      |\n",
    "| n_red_flags_msa_clinic_certified                               | numeric     | Clinically certified number of red flags.                                        |\n",
    "| parkinsonism                                                   | numeric     | Severity/composite score of parkinsonian signs (rigidity, bradykinesia, tremor). |\n",
    "| percentuale_risposta_ldopa                                     | numeric     | % improvement after acute L-Dopa test.                                           |\n",
    "| progression_rate                                               | numeric     | Calculated progression speed (e.g. H&Y / disease years).                         |\n",
    "| ritardo_diagnostico                                            | numeric     | Diagnostic delay (years from symptom onset to diagnosis).                        |\n",
    "| updrs_off                                                      | numeric     | UPDRS-III motor score in OFF-medication state.                                   |\n",
    "| updrs_on                                                       | numeric     | UPDRS-III motor score in ON-medication state.                                    |\n",
    "| atrofia_cervelletto                                            | binary      | MRI: cerebellar atrophy.                                                         |\n",
    "| atrofia_del_putamen                                            | binary      | MRI: putaminal atrophy.                                                          |\n",
    "| atrofia_peduncoli_cerebellari_medi                             | binary      | MRI: middle cerebellar peduncle atrophy.                                         |\n",
    "| atrofia_ponte                                                  | binary      | MRI: pontine atrophy.                                                            |\n",
    "| behavioural_alteration                                         | binary      | Behavioural or personality changes.                                              |\n",
    "| caduta_segnale_putamen                                         | binary      | MRI: putaminal signal loss on T2*/SWI.                                           |\n",
    "| cadute                                                         | binary      | History of falls.                                                                |\n",
    "| carrozzina                                                     | binary      | Wheelchair use.                                                                  |\n",
    "| cerebellar_syndrome                                            | binary      | Presence of cerebellar signs (ataxia, dysmetria).                                |\n",
    "| cognitive_decline                                              | binary      | Cognitive impairment or dementia.                                                |\n",
    "| cold_discolored_hands_and_feet                                 | binary      | Peripheral vasomotor disturbance (autonomic).                                    |\n",
    "| constipation                                                   | binary      | Chronic constipation.                                                            |\n",
    "| craniocervical_dyst_induced_dy_l_dopa                          | binary      | Craniocervical dystonia induced by L-Dopa.                                       |\n",
    "| deambulaz_appoggio                                             | binary      | Ambulates with support.                                                          |\n",
    "| deambulaz_autonoma                                             | binary      | Ambulates independently.                                                         |\n",
    "| drooling                                                       | binary      | Hypersalivation / drooling.                                                      |\n",
    "| erectile_disfunction                                           | binary      | Erectile dysfunction (autonomic symptom).                                        |\n",
    "| fatigue                                                        | binary      | Fatigue / lack of energy.                                                        |\n",
    "| hot_cross_bun_sign                                             | binary      | MRI: pontine cruciform hyperintensity typical of MSA-C.                          |\n",
    "| hyposmia                                                       | binary      | Reduced sense of smell.                                                          |\n",
    "| inspiratory_sighs                                              | binary      | Sighing or irregular breathing pattern.                                          |\n",
    "| iperintensita_peduncoli_cerebellari_medi                       | binary      | MRI: MCP hyperintensity.                                                         |\n",
    "| iperintensita_putamen                                          | binary      | MRI: putaminal hyperintensity.                                                   |\n",
    "| jerky_myoclonic_postural_or_kinetic_tremor                     | binary      | Irregular / jerky tremor type.                                                   |\n",
    "| moderate_to_severe_postural_instability_w_3_yrs_of_motor_onset | binary      | Postural instability within 3 years of motor onset.                              |\n",
    "| normal_rmn                                                     | binary      | Normal brain MRI.                                                                |\n",
    "| pain                                                           | binary      | Chronic or neuropathic pain.                                                     |\n",
    "| pathologic_laughter_or_crying                                  | binary      | Emotional incontinence (pseudobulbar affect).                                    |\n",
    "| poor_l_dopa_responsivenes                                      | binary      | Poor or absent clinical response to L-Dopa.                                      |\n",
    "| postural_deformities                                           | binary      | Axial/postural deformities (camptocormia, Pisa).                                 |\n",
    "| rapid_progression_w_3_yrs                                      | binary      | Rapid disease progression within 3 years.                                        |\n",
    "| rbd                                                            | binary      | REM sleep behavior disorder.                                                     |\n",
    "| russamento_osas                                                | binary      | Snoring / sleep apnea (OSAS).                                                    |\n",
    "| severe_dysphagia_w_3_yrs                                       | binary      | Severe dysphagia within 3 years of onset.                                        |\n",
    "| severe_speech_impairement_w_3_yrs                              | binary      | Severe dysarthria within 3 years of onset.                                       |\n",
    "| sonnolenza_diurna                                              | binary      | Excessive daytime sleepiness.                                                    |\n",
    "| stridor                                                        | binary      | Laryngeal stridor (inspiratory noise).                                           |\n",
    "| unexplained_babinski                                           | binary      | Pathological Babinski sign unexplained by stroke.                                |\n",
    "| unexplained_urinary_urge_incontinence                          | binary      | Urinary urge incontinence unexplained by obstruction.                            |\n",
    "| unexplained_voiding_difficulties                               | binary      | Urinary retention / difficulty voiding unexplained by prostate disease.          |\n",
    "| visual_alteration                                              | binary      | Visual disturbances or blurring.                                                 |\n",
    "| anamnestic_oh                                                  | binary      | History of orthostatic hypotension from anamnesis.                               |\n",
    "| diagnosi_definita                                              | categorical | Final confirmed diagnosis (PD / MSA-P / MSA-C / Control).                        |\n",
    "| diagnosi_di_invio                                              | categorical | Referral diagnosis at first evaluation.                                          |\n",
    "| gruppo_eta                                                     | categorical | Age group (e.g. <50, 50-60, 60-70, >70).                                         |\n",
    "| sesso                                                          | categorical | Sex (M/F).                                                                       |\n",
    "| stadio_malattia                                                | categorical | Disease stage grouping (e.g. early / mid / late).                                |\n",
    "| data_di_nascita                                                | date        | Full birth date.                                                                 |\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "16fdff33",
   "metadata": {},
   "source": [
    "pointed by Grazia"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "093091dc",
   "metadata": {},
   "source": [
    "| **Set**                           | **Variables Included**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |\n",
    "| --------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------                                                                                                                                                                          |\n",
    "| **Clinician-Certified MSA Red Flags** | `poor_l_dopa_responsivenes`, `rapid_progression_w_3_yrs`, `moderate_to_severe_postural_instability_w_3_yrs_of_motor_onset`, `craniocervical_dyst_induced_dy_l_dopa`, `severe_speech_impairement_w_3_yrs`, `severe_dysphagia_w_3_yrs`, `unexplained_babinski`, `jerky_myoclonic_postural_or_kinetic_tremor`, `postural_deformities`, `unexplained_voiding_difficulties`, `unexplained_urinary_urge_incontinence`, `stridor`, `inspiratory_sighs`, `cold_discolored_hands_and_feet`, `pathologic_laughter_or_crying` |\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Data Ingestion and Harmonization\n",
    "\n",
    "- Load clinical csv (harmonizing different rapresentations of missing values to Nan)\n",
    "- Column names normalized: Unicode stripped, whitespace collapsed, then slugified to ASCII snake_case.\n",
    "- Diagnosis labels trimmed and harmonized (e.g., `MSA-P/C` ‚Üí `MSA-P`).\n",
    "- Numeric casting based on patterns; categorical cleaning (uppercasing, NA handling).\n",
    "- Duplicates check\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Missingness Profiling\n",
    "\n",
    "- Quantify missingness per variable per class to guide usable features.\n",
    "\n",
    "\n",
    "<!-- ![Missingness by variable](../images/missing_by_variable.png) -->\n",
    "<!-- ![Missing MSA-P](../images/missing_by_variable_MSA-P.png) -->\n",
    "![Missing PD](../images/missing_by_variable_PD.png)\n",
    "![Missing MSA](../images/missing_by_variable_MSA.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9d0740bd",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(33, 150, 243, 0.15); border-left: 6px solid #2196F3; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üìù NOTE:</strong> which thrashold do i keep?\n",
    "</div>\n",
    "\n",
    "<div style=\"background-color: rgba(220, 53, 69, 0.15); border-left: 6px solid #DC3545; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üö® IMPORTANT:</strong> Note that PD has much more missings\n",
    "</div>\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1d8dc4ca",
   "metadata": {},
   "source": [
    "**Remaining columns after removal of high missing columns**\n",
    "\n",
    "![remaining_columns](../images/missing_by_variable_after_removal.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "03d2fdeb",
   "metadata": {},
   "source": [
    "## 4. Derived Variables and Cleaning\n",
    "\n",
    "- Create analysis-friendly fields (examples):\n",
    "  - Timing/severity: `eta_attuale`, `eta_esordio`, `durata_malattia`, `percentuale_risposta_ldopa`.\n",
    "  - Aggregates: `n_red_flags_msa`, `n_anomalie_mri` as the sum of the corresponding binary symptoms columns\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7665f2a1",
   "metadata": {},
   "source": [
    "| Variable                               | Short description                                                      |\n",
    "|---------------------------------------:|------------------------------------------------------------------------|\n",
    "| eta_attuale                            | Current patient age.                                                   |\n",
    "| ritardo_diagnostico                    | Diagnostic delay (years from symptom onset to diagnosis).              |\n",
    "| anni_dalla_diagnosi                    | Years elapsed since formal diagnosis.                                  |\n",
    "| percentuale_risposta_ldopa             | % improvement after acute L‚ÄëDopa test.                                 |\n",
    "| ledd_per_anno                          | Levodopa equivalent daily dose normalized per year of disease.         |\n",
    "| n_red_flags_msa                        | Count of MSA ‚Äúred-flag‚Äù AI generated.                            |\n",
    "| n_red_flags_msa_clinic_certified       | Clinically certified count od MSA red flags.                              |\n",
    "| n_anomalie_mri                         | Number of abnormal MRI findings.                                       |\n",
    "| stadio_malattia                        | Disease stage grouping (e.g. early / mid / late).                      |\n",
    "| gruppo_eta                             | Age group (e.g. <50, 50-60, 60-70, >70).                               |\n",
    "| progression_rate                       | Calculated progression speed (e.g. H&Y / disease years).               |"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5. Outlier Detection\n",
    "\n",
    "- Use Tukey's fences on key continuous variable to spot extreme values.\n",
    "- Provides a record of suspected outliers for clinician review.\n",
    "\n",
    "**Method**: Tukey's Fences\n",
    "- Lower fence = Q1 ‚àí 1.5 √ó IQR  \n",
    "- Upper fence = Q3 + 1.5 √ó IQR\n",
    "- Values outside these fences are flagged as outliers\n",
    "\n",
    "![Outlier distributions](../images/outliers_boxplots_by_diagnosis.png)\n",
    "![Outlier Summary Table](../images/tables/outlier_details_consolidated.png) \n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "07379a04",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(255, 193, 7, 0.15); border-left: 6px solid #FFC107; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>‚ö†Ô∏è TODO:</strong> Make clinician verify outliers and decide what to do with those\n",
    "</div>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4002d74c",
   "metadata": {},
   "source": [
    "## 6. Cohort Overview\n",
    "\n",
    "- Distribution of patients across definitive diagnoses.\n",
    "- A compact summary table (N, M/F, age at onset, duration, current age).\n",
    "\n",
    "![Patient distribution by diagnosis](../images/tables/summary_table.png)\n",
    "<br>\n",
    "\n",
    "![diag barchart](../images/diag_barchart.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "34568433",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(220, 53, 69, 0.15); border-left: 6px solid #DC3545; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üö® WARNING:</strong> PD patients are predominantly males\n",
    "</div>\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0a1e7aed",
   "metadata": {},
   "source": [
    "\n",
    "![diag barchart](../images/sex_pat_comp_3class.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0bb94c0f",
   "metadata": {},
   "source": [
    "![violin_plots](../images/sex_pat_comp_2class.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bf32bf4b",
   "metadata": {},
   "source": [
    "![diag barchart](../images/age_distribution_violin_plots.png)\n",
    "![diag barchart](../images/age_distribution_histograms.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 7. Multi-symtoms clusters and Co-occurrence\n",
    "\n",
    "This analysis identifies and visualizes patterns of symptom co-occurrence within each diagnostic group (MSA-P, MSA-C, PD) to reveal characteristic multi-symptom profiles that may aid differential diagnosis.\n",
    "\n",
    "**Rationale:**\n",
    "While univariate symptom prevalence identifies individual discriminators, parkinsonian syndromes are clinically characterized by specific constellations of concurrent symptoms.\n",
    "\n",
    "<!-- ![Binary symptom prevalence (PD vs MSA)](../images/symptom_prevalence_pd_vs_msa.png) -->\n",
    "\n",
    "<!-- ![Symptom co-occurrence (Jaccard)](../images/symptom_jaccard_heatmaps.png) -->\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b195feaf",
   "metadata": {},
   "source": [
    "![Symptom clusters (UpSet view)](../images/symptom_upset_plots_MSA_P_and_C.png)\n",
    "\n",
    "![Symptom clusters 2 (UpSet view)](../images/symptom_upset_plots_MSA-P.png)\n",
    "\n",
    "![Symptom clusters 3 (UpSet view)](../images/symptom_upset_plots_MSA-C.png)\n",
    "\n",
    "![Symptom clusters 4 (UpSet view)](../images/symptom_upset_plots_PD.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3377fb43",
   "metadata": {},
   "source": [
    "## 7.1 symptoms co-occurence heatmaps"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "baa60d94",
   "metadata": {},
   "source": [
    "This analysis quantifies pairwise symptom co-occurrence within each diagnostic group using the Jaccard similarity coefficient, revealing which symptoms tend to appear together in **individual patients**.\n",
    "\n",
    "**Methods:**\n",
    "- **Jaccard index**: For each symptom pair, computed as the ratio of co-occurrence (intersection) to total presence (union): J(A,B) = |A ‚à© B| / |A ‚à™ B|\n",
    "- **Scale**: Ranges from 0 (symptoms never co-occur) to 1 (perfect overlap‚Äîevery patient with symptom A also has symptom B, and vice versa)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e9665939",
   "metadata": {},
   "source": [
    "![Symptom co-occurrence (Jaccard)](../images/symptom_jaccard_heatmap_MSA_P_and_C.png)\n",
    "\n",
    "![Symptom co-occurrence (Jaccard)](../images/symptom_jaccard_heatmap_MSA-P.png)\n",
    "\n",
    "![Symptom co-occurrence (Jaccard)](../images/symptom_jaccard_heatmap_MSA-C.png)\n",
    "\n",
    "![Symptom co-occurrence (Jaccard)](../images/symptom_jaccard_heatmap_PD.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3eae8b04",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(33, 150, 243, 0.15); border-left: 6px solid #2196F3; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üìù NOTE:</strong> PD heatmaps lacks columns of the symptoms which are always not expressed (ie set to 0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 8. Motor Function and L‚ÄëDopa Responsiveness\n",
    "**Objective:** Compare motor severity (UPDRS OFF) and treatment response across diagnoses. higher UPDRS values means severe motor impairment\n",
    "\n",
    "**Clinical Relevance:**\n",
    "- **UPDRS OFF score:** Measures motor impairment without medication, reflecting disease severity\n",
    "- **L-dopa responsiveness:** **KEY DIAGNOSTIC CRITERION** distinguishing MSA from PD\n",
    "  - PD: Typically >30% improvement with L-dopa (good response)\n",
    "  - MSA: Poor L-dopa response (<30% improvement) is a core diagnostic feature\n",
    "\n",
    "**Clinical Importance:**\n",
    "This is one of the most critical clinical differentiators between MSA and PD\n",
    "\n",
    "**Expected Findings:**\n",
    "- Similar or higher UPDRS OFF scores in MSA (more severe motor impairment)\n",
    "- Significantly lower L-dopa response in MSA vs. PD\n",
    "- High inter-individual variability, especially in MSA\n",
    "\n",
    "**Results**\n",
    "- expected finding one and two are respected (can also be seen by the slope of the graph plotting values of UPDRS OFF and ON)\n",
    "- although MSA-P presents outliers it doesnt show higher variability than PD\n",
    "\n",
    "![Symptom clusters (UpSet view)](../images/ldopa_response_comparison.png)\n",
    "\n",
    "<!-- ![Symptom clusters (UpSet view)](../images/motor_function_on_off_comparison.png) -->\n",
    "\n",
    "![Symptom clusters (UpSet view)](../images/motor_function_paired_trajectories.png)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 9. MSA Red Flags and Hoehn & Yahr Severity\n",
    "\n",
    "**Objective:** Quantify MSA-specific clinical red flags and assess disease staging.\n",
    "\n",
    "**Clinical Relevance:**\n",
    "- **Red flags:** Clinical features suggestive of MSA (e.g., rapid progression, early autonomic failure, poor L-dopa response, cerebellar signs)\n",
    "- **Hoehn & Yahr (H&Y) staging:** Standard PD staging system (0-5), also applicable to parkinsonian disorders\n",
    "  - Stage 1-2: Unilateral/bilateral involvement, no balance impairment\n",
    "  - Stage 3: Balance impairment, physically independent\n",
    "  - Stage 4-5: Severe disability, wheelchair-bound\n",
    "\n",
    "![Red flags and H&Y severity](../images/red_flags_severity_clinician_certified.png)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e73eee01",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(220, 53, 69, 0.15); border-left: 6px solid #DC3545; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üö® IMPORTANT:</strong> MSA patients are overwhelmingly in worse disease stages than PD ones\n",
    "</div>\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 10. Diagnostic Delay and Progression\n",
    "\n",
    "**Objective:** Quantify time from symptom onset to diagnosis and calculate progression rates.\n",
    "\n",
    "**Clinical Relevance:**\n",
    "- **Diagnostic delay:** Time between symptom onset and formal diagnosis\n",
    "  - Reflects diagnostic complexity and symptom overlap between conditions\n",
    "  - Longer delays may indicate atypical presentations\n",
    "- **Progression rate:** Speed of clinical decline (e.g., H&Y stage change per year)\n",
    "  - MSA progresses faster than PD (key differentiator)\n",
    "  - Rapid progression within 3 years is an MSA red flag\n",
    "\n",
    "**Expected Findings:**\n",
    "- MSA may show longer diagnostic delays due to initial misdiagnosis as PD\n",
    "- MSA demonstrates faster progression rates than PD\n",
    "- High variability in both measures reflects diagnostic complexity\n",
    "\n",
    "**Results Analysis**\n",
    "- all expected findings are respected\n",
    "![Diagnostic delay and progression](../images/diagnostic_delay_progression.png)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 11. MRI Abnormalities (Supportive Features)\n",
    "\n",
    "- Total abnormality count by diagnosis; specific signs: hot‚Äëcross‚Äëbun, putamen atrophy/signal changes.\n",
    "- Clinical reading: MSA‚ÄëC shows pontocerebellar signs; MSA‚ÄëP shows putaminal changes; PD often near-normal MRI.\n",
    "\n",
    "![MRI findings comparison](../images/mri_findings_comparison.png)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 12. Autonomic Dysfunction Profile (COMPASS)\n",
    "\n",
    "- Compare subscales COMPASS across classes.\n",
    "\n",
    "![COMPASS subscales comparison](../images/compass_subscales_comparison.png)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "32086cd3",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(220, 53, 69, 0.15); border-left: 6px solid #DC3545; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üö® IMPORTANT:</strong> COMPASS is a high missing value (almost 40%) expecially for PD patients where almost 80% of them do not have a compass value\n",
    "</div>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 13. Univariate Screening and Mutual Information\n",
    "\n",
    "Since the dataset contains both continouse (with different distribution) and categorical features proper statistical tests on early diagnoses features (ie features that a patient could present before being diagnosed/at first clinical visit) to understand which of those are statistically more relevant to distinguish diagnoses class and could potentially be integrated into a ML model.\n",
    "\n",
    "- For each feature: appropriate test (ANOVA/Welch/Kruskal for continuous (decision based on feature distribution ie if they respect normality and homoschedacity); Chi‚Äësquare for binary).\n",
    "- Effect sizes and p-values aggregated and adjusted using FDR (Benjamini‚ÄìHochberg False Discovery Rate)\n",
    "- **Mutual Information (MI)** is computed for each feature to quantify\n",
    "any **non-linear dependencies** between that variable and the diagnosis, beyond\n",
    "what ANOVA captures.\n",
    "\n",
    "- A combined visualization summarizes top features by q-value/effect and MI.\n",
    "\n",
    "- the best top K(=10) features (for both MI and ANOVA/Kruskal) are taken to be used with ML model.\n",
    "\n",
    "![Feature importance analysis](../images/feature_importance_analysis.png)\n",
    "\n",
    "![importance analysis](../images/feature_importance_analysis_top_10.png)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 14. Differential and Within‚ÄëDiagnosis Correlations\n",
    "\n",
    "- Differential correlations: identify pairs of continouse variables whose association differs between diagnoses.\n",
    "- Within‚Äëdiagnosis correlation heatmaps (MSA‚ÄëP, MSA‚ÄëC, PD) for key clinical variables.\n",
    "\n",
    "**Method:**\n",
    "1. Calculate correlation matrices **separately** for each diagnosis (MSA-P, MSA-C, PD)\n",
    "2. For each variable pair, compute the **maximum absolute difference** in correlation coefficients across groups:\n",
    "$$\n",
    "\\text{Max Diff} = \\max\\big( \\; |r_{\\text{MSA-P}} - r_{\\text{PD}}|,\\quad |r_{\\text{MSA-C}} - r_{\\text{PD}}|,\\quad |r_{\\text{MSA-P}} - r_{\\text{MSA-C}}| \\; \\big)\n",
    "$$\n",
    "3. Rank pairs by Max Diff to identify **most differentially correlated** relationships\n",
    "\n",
    "![Differential correlations](../images/differential_correlations.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bcd718bb",
   "metadata": {},
   "source": [
    "### Main Insights\n",
    "\n",
    "- **Autonomic‚ÄìStructural Link**  \n",
    "  *Compass Totale* increases with *N¬∞ Anomalie MRI* only in **MSA-P**, suggesting that structural damage (putamen/cerebellum) parallels autonomic failure ‚Äî absent in PD.\n",
    "\n",
    "  strange MSA-C inverse correlation.\n",
    "\n",
    "- **Disease Duration Effect**  \n",
    "  *Compass Totale* rises with *Durata Malattia* in in PD and MSA-C indicating **progressive autonomic decline**\n",
    "\n",
    "  strange  MSA-P inverse relationship\n",
    "\n",
    "\n",
    "- **Medication Dynamics**  \n",
    "  - In PD, *LEDD* scales with disease duration (normal titration).  \n",
    "  - In MSA, higher *LEDD* does **not** improve *Compass Totale* or *Progression Rate* as much as it does for Pd patients consistent with **poor dopaminergic responsiveness** of MSA.\n",
    "\n",
    "- **Motor‚ÄìAutonomic Coupling**  \n",
    "  *H&Y* correlates positively with *Compass Totale* and *Progression Rate* in MSA, but not in PD supporting **parallel motor and autonomic progression** in MSA.\n",
    "\n",
    "- **Diagnostic Red Flags**  \n",
    "  Patients with low *% L-dopa response* show more *MSA red flags*, consistent with **poor dopaminergic responsiveness** of MSA.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1f22a783",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(220, 53, 69, 0.15); border-left: 6px solid #DC3545; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>üö® IMPORTANT:</strong> COMPASS is a high missing value (almost 40%) expecially for PD patients where almost 80% of them do not have a compass value\n",
    "</div>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a6691a05",
   "metadata": {},
   "source": [
    "## Within diagnosis symptoms correlation (Pearson)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "acaa5505",
   "metadata": {},
   "source": [
    "![Correlation heatmap (MSA-P)](../images/correlation_matrix_MSA-P.png)\n",
    "![Correlation heatmap (MSA-C)](../images/correlation_matrix_MSA-C.png)\n",
    "![Correlation heatmap (PD)](../images/correlation_matrix_PD.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 15. ML model integration\n",
    "\n",
    "Highly discriminative easy‚Äëto‚Äëcollect features are selected (selected in step 13):\n",
    "\n",
    " - 'unexplained_urinary_urge_incontinence'\n",
    " - 'russamento_osas'\n",
    " - 'anamnestic_oh'\n",
    " - 'sonnolenza_diurna'\n",
    " - 'cold_discolored_hands_and_feet'\n",
    " - 'cerebellar_syndrome'\n",
    " - 'postural_deformities'\n",
    " - 'parkinsonism'\n",
    " - 'constipation'\n",
    " - 'jerky_myoclonic_postural_or_kinetic_tremor'\n",
    "\n",
    "few simple ML/statistical models are used to make predictions.\n",
    " - dummy = random guess\n",
    " - logistic regression (logreg)\n",
    " - random forest (rf)\n",
    "\n",
    "8 fold cross validation is performed\n",
    "\n",
    "The **Matthews Correlation Coefficient (MCC)** is included as a key metric for model evaluation instead of f1.\n",
    "- **MCC** is a balanced measure, even for imbalanced classes, giving a value between -1 (inverse prediction) and +1 (perfect prediction); 0 indicates random performance.\n",
    "\n",
    "\n",
    "![model comparisons](../images/model_comparison_tables/model_comparison_summary_MSA-P_PD_full-selected-features.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1129ff4",
   "metadata": {},
   "source": [
    "**OUT OF FOLD CONFUSION MATRIX**\n",
    "aggregates prediction for each test fold data. ie these are the prediction aggregated over each fold test set\n",
    "![model conf_matrix](../images/confusion_matrices.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0807e3b8",
   "metadata": {},
   "source": [
    "with smaller selected features = \n",
    "1. sonnolenza_diurna\n",
    "2. n_red_flags_msa_clinic_certified\n",
    "3. cerebellar_syndrome\n",
    "4. unexplained_urinary_urge_incontinence\n",
    "5. cold_discolored_hands_and_feet\n",
    "6. anamnestic_oh\n",
    "7. russamento_osas\n",
    "8. constipation"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb2254d3",
   "metadata": {},
   "source": [
    "aggregates prediction for each test fold data. ie these are the prediction aggregated over each fold test set\n",
    "![model comp](../images/model_comparison_summary_MSA-P_PD.png)  "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7ee5715c",
   "metadata": {},
   "source": [
    "<div style=\"background-color: rgba(255, 193, 7, 0.15); border-left: 6px solid #FFC107; padding: 10px; margin: 10px 0; color: inherit;\">\n",
    "<strong>‚ö†Ô∏è TODO:</strong> Clinician features review\n",
    "</div>"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "name": "python",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
